LABORATORIES
Bioanalysis and Onco-Pharmaceutics
Faculty
Introduction
We aim to analyze the distinctive characteristics of cancer cells and tumor tissue including the tumor microenvironment, develop new tools to treat, diagnose, and predict cancers.
Welcome to our Laboratory’s website! Our research goal is to help cancer patients who suffer from refractory disease resume everyday life with a better quality of life by developing new therapeutic and diagnostic strategies. Since cancer is still a life-threatening disease and bothers a number of patients mentally and physically, our research focuses mainly on cancer, more specifically, breast cancer. As one of the university’s core missions is to educate undergraduate and graduate students, we also aim to provide support to achieve their academic goals.
As humans, we have faced health problems associated with refractory diseases including cancer for a long time. Although substantial efforts by scientists, researchers, and oncologists have permitted us to understand the characteristics of cancers better and to develop new anticancer drugs, cancer is still the leading cause of death worldwide and remains incompletely understood. Further elucidation of molecular mechanisms of cancer cells including metastases, drug resistance, and recurrence, and the development of new therapeutic and diagnostic strategies will lead to extending patients’ life.
With our expertise in drug delivery and molecular imaging, our research focuses on developing new therapeutic/diagnostic strategies and a prognostic biomarker to overcome refractory diseases including cancer. Notably, we developed an MRI-based imaging technique to visualize drug release noninvasively and discovered the potential prognostic biomarker of breast cancer in the past. Our team has skills to perform in vitro, in vivo, and ex vivo experiments, such as, but not limited to, toxicological evaluation, the use of in vivo tumor models, and in vivo optical imaging to further elucidate the characteristics of cancer cells and tumor tissue. For more details on our projects, please refer to the pages “Publications” and “Ongoing Projects” on our website.
We have been collaborating with other scientists nationally and internationally and are willing to continue to do so. Hoshi University is located in Tokyo, and it takes within an hour from Tokyo International Airport, aka Haneda Airport (HND). Please email us if you want to work with us or join our laboratory!
Keywords: cancer therapy/diagnosis, molecular imaging, drug delivery system, biomarker, tumor microenvironment, cell experiments, in vivo experiments, toxicological evaluation